Doctor Tatsiana Vaitsiakhovich
Bayer AG, Berlin (Germany)
Worsening of renal function in atrial fibrillation patients with stage 3 or 4 chronic kidney disease treated with warfarin or rivaroxaban - evidence from the real-world CALLIPER study in the US claims
Event: ESC Congress 2019
Topic: Oral Anticoagulation
Session: Atrial fibrillation and oral anticoagulation 1
ESC 365 is supported by
